Capital rushes into pharmaceutical funds, with some products seeing their scale increase more than 40-fold in a single quarter.

Based on the latest disclosed fund third-quarter report data, pharmaceutical-themed funds have achieved rapid scale growth due to large inflows of subscriptions. As the sector style switched in the third quarter, a large amount of retail capital turned to the pharmaceutical sector, and a large number of pharmaceutical fund products achieved several-fold growth in scale within a short period, with some pharmaceutical funds growing more than 40 times within three months. A large amount of capital flowed to pharmaceutical funds for risk avoidance, which also further broadened fund managers' room for operation.